Obesity Drugs' Next Wave: These Companies Could Snag 20% of GLP-1 Market, Analysts Say

MarketWatch12:00 ET

Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?

Yahoo FinanceAug 26 04:57 ET

Why Viking Therapeutics Is Thriving in the $150 Billion Weight Loss Drug Market

Yahoo FinanceAug 25 14:14 ET

Eli Lilly, Novo Nordisk to Maintain 'Two Horse Race' in GLP-1 Weight Loss Market

Seeking AlphaAug 25 14:00 ET

Director J Singleton Sells 5,700 Shares of Viking Therapeutics Inc (VKTX)

InvestingAug 22 19:01 ET

Viking Therapeutics Could Be a New Winner in the GLP-1 Space

Yahoo FinanceAug 21 16:50 ET